St. Johns Investment Management’s Biogen BIIB Stock Holding History

St. Johns Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-60	Closed	-$25K	–	144
2015 Q1	$25K	Hold	60	–	–	0.02%	95
2014 Q4	$20K	Hold	60	–	–	0.02%	98
2014 Q3	$20K	Hold	60	–	–	0.02%	94
2014 Q2	$19K	Buy	+60	New	+$18.1K	0.02%	103

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

St. Johns Investment Management's BIIB Position: Q2 2015 in Review

St. Johns Investment Management sold out of Biogen (BIIB) in Q2 2015, closing a stake of 60 shares — an estimated $25K sold.

St. Johns Investment Management first reported a position in BIIB in Q2 2014 and held it in 4 quarters. The position peaked at $25K in Q1 2015. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

St. Johns Investment Management reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
St. Johns Investment Management sold 60 Biogen shares in Q2 2015, an estimated $25K.
St. Johns Investment Management first reported a position in Biogen in Q2 2014 and held it in 4 quarters.
St. Johns Investment Management's Biogen position peaked at $25K in Q1 2015.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on St. Johns Investment Management's 13F filing for Q2 2015, filed 16 Jul 2015.